Home

Health Family

Board of Directors

Vision and mission

Social involvement

Sustainability Report

History

Quality Standards

Company

ADHD

Nephrology with a System

VELARIQ® is a prescription-only medicine. For more information about this product, please refer to the package leaflet.

Urology

Self-medication

Therapeutic Areas

ADHD in adults

ADHD in the paediatric population

Anemia

Bladder dysfunction

Common cold

Urinary tract infections

Dermatosis

Insomnia

Diarrhea

Nephrology

Revitalization

Pain

Sialorrhö / Hypersalivation

Vitamin Substitution

Women's Health

Tooth rescue

Our products

News & Stories

MEDICE receives award for "family friendly company".

MEDICE: family friendly company

Medikinet retard secures a registration expansion in 11 more European countries for the treatment of ADHD in adults

Medikinet retard now in 11 more European countries

NEW within the MEDICE-portfolio: Alflorex® against irritable colon syndrome!

NEW: Alflorex®

Two new international MEDICE-subsidiaries in Norway and Denmark

MEDICE in Norway and Denmark

New address for your way to MEDICE

One of the main challenges for 2020 was launching Medikinet Retard in Costa Rica. The official launch event was scheduled and organized for March 2020, when COVID-19 was classified as a global pandemic.

Business Development Activities During COVID-19

Meditonsin is THE OTC preparation with the highest customer recommendation rating in Germany.

Recommendation champion - Meditonsin takes first place

Helge Braun, Head of the Federal Chancellor's Office, stopped off in Iserlohn on Thursday, 14.08.2020 and visited pharma corporation MEDICE and the Iserlohn local newspaper IKZ.

Helge Braun visiting MEDICE

BAH and BPI throw away historic opportunity

The Pütter family at Medice focus on innovative quality products, with the employee taking centre place. 

"Revolutionary rethinking in our work environment"

 the modern alternative for insect bites.

NEW: Soventol® itch relief spray

Pharmaceutical producer from Westphalia takes aim at the Russian market. 

MEDICE opens a subsidiary in Moscow

In-house honey - since the spring, this has been provided by three bee colonies which have taken up residence on the MEDICE company site.

MediBee – MEDICE launches its own bee project

Modern office premises in the heart of Cologne give MEDICE employees the opportunity to work near their homes.

MEDICE opens its second site in Cologne

Resistance to antibiotics is advancing around the world and, according to the World Health Organisation, is threatening to destroy decades of research.

Herbal remedy for urinary tract infections

Medicovid SARS-CoV-2 IgG/IgM rapid test is an EU-licensed, CE-certified in-vitro diagnostic rapid test for the qualitative and semi-quantitative detection of IgM and IgG antibodies against the SARS-CoV-2 coronavirus in human serum or whole blood (obtained via venipuncture). The test combines immunoassay and chromatography and produces a result from venous whole blood within 15 minutes at the point of care with a proven high degree of sensitivity to IgM and IgG of 96.2% and a high level of specificity of 97.9% with the test remaining unresponsive to antibodies of other coronaviruses (HKU1, OC43, NL63, 229E) or chlamydia and mycoplasmas. 

New: Medicovid SARS-CoV-2 IgG/IgM rapid antibody test

Iserlohn. With immediate effect, MEDICE markets a SARS-CoV-2 rapid antigen test and so adds to its SARS-CoV-2 rapid test portfolio. 

New: Medicovid-AG® SARS-CoV-2 rapid antigen test

Since 1 November 2020, the skin product portfolio of MEDICE has grown to include the innovative medical skincare product AktivaDerm® ND, a skincare treatment with active probiotics for neurodermatitis.

AKTIVADERM® ND - The first skincare treatment with active probiotics for neurodermatitis

The specialist herbal treatment for dry irritating coughs. 

New from MEDICE: STILAXX® COUGH SUPPRESSANT

The latest generation of Medicovid-AG SARS-CoV-2 Antigen Self-Test, capable of qualitative detection of the specific SARS-CoV-2 antigen through human nasal swabs, is now approved for self-testing.

MEDICE receives special approval for the self-testing of lay persons

Iserlohn, 28.4.2021. With the acquisition of 60 percent of company shares, MEDICE Arzneimittel Pütter GmbH joins Schaper & Brümmer on 23.04.2021 as the new majority owner.

Joining Forces: MEDICE acquires majority stake in Schaper & Brümmer

30.04.2021. For more than 70 years, Medice has been supporting patients and physicians with spirit and innovative strength as well as a regionally connected production.

10 years of adult ADHD therapy

The expansion of operations in Iserlohn, the headquarters of MEDICE Arzneimittel Pütter GmbH & Co. KG, continues with the addition of a new dispatch building directly next to the entrance on Medice Allee. 

MEDICE Constructs Sustainable Building for Shipments

Millions of Medicovid-AG SARS-CoV-2 Antigen Self-tests have already been successfully used. 

MEDICE Supports Widespread Pandemic Containment

The purchase of the majority of shares of Schaper & Brümmer is part of a systematically-driven transformation process of the pharmaceutical company MEDICE towards a holistically-operating health care company, which, in addition to the classic pharmaceutical business, will increasingly focus on the future markets "Digital Health" and "Sustainability" in close cooperation with the two newly founded companies "MediVentures" and "Sustainable4U"," said the two MEDICE shareholders Dr. Katja Pütter Ammer and Dr. Dr. Richard Ammer. 

MEDICE Repositions Itself

English (German)

Assets

Welcome to the MEDICE Health Family

Latest News

BKK Pfalz now supports its policyholders with the femfeel online course and the MEDICE Health Family menopause app.

Better through the menopause thanks to the femfeel app: BKK Pfalz launches partnership with the MEDICE Health Family

The MEDICE Health Family acquires Selfapy, one of the best-known German digital health pioneers for mental illnesses.

MEDICE - The Health Family acquires Selfapy and becomes one of the leading providers of mental health therapies

MEDICE had reason to celebrate this year. 2024 marked the 75th anniversary of the company's founding. The family business is now run by the third generation - and they look back fondly on their roots.

From pharmaceuticals to multimodal healthcare solutions

GAIA, a global leader in the development of digital therapeutics, today announced the signing of a licensing agreement for attexis® with MEDICE Arzneimittel Pütter GmbH & Co. KG (MEDICE – The Health Family).

GAIA and MEDICE Sign Licensing Agreement for the Commercialization of attexis® for Adults with ADHD in Germany

The MEDICE Health Family invests in the fund to promote innovative, digital business models in the healthcare sector.

MEDICE Health Family invests in new Heal Capital fund for digital health innovations

The MEDICE Health Family was recently awarded silver in the “Best Design: Pharmacy & Medicines” category at the prestigious Vision.A Awards 2024.

MEDICE Health Family wins Vision.A Award 2024 in silver in the category “Best Design: Pharmacy & Medicines”

With the addition of Vafseo® to our portfolio, we are taking anaemia therapy for dialysis patients to a new level.

Vafseo®: a new perspective for anaemia anaemia therapy for dialysis patients

As part of the company's 75th anniversary celebrations, MEDICE called on its guests to support the environmental education work of NaturSpielWerkstatt Lindenhaus e.V. at the Stiftungshof with a donation instead of gifts.

MEDICE - The Health Family is supporting the current project of NaturSpielWerkstatt Lindenhaus e.V. - a "hands-on workshop"

Relaunch of the entire OTC packaging design of the MEDICE Health Family

With this partnership, the Health Family is emphasising its commitment to sport and the health of athletes for the third time, after MEDICE already supported Team Germany in Tokyo in 2020 and in Beijing in 2022.